Suppr超能文献

对多粘菌素耐药的铜绿假单胞菌被归为 ST245:巴西圣保罗一家重症监护病房的首次报告。

Polymyxin-resistant Pseudomonas aeruginosa assigned as ST245: First report in an intensive care unit in São Paulo, Brazil.

机构信息

Department of Infectious Diseases and LIM-54, Universidade de São Paulo, Av. Dr Enéas de Carvalho Aguiar 470, São Paulo - SP, 05403-000, Brazil.

Department of Infectious Diseases and LIM-54, Universidade de São Paulo, Av. Dr Enéas de Carvalho Aguiar 470, São Paulo - SP, 05403-000, Brazil; Department of Infection Control of Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Rua Dr Ovídio Pires de Campos 225, Sala 629, São Paulo - SP, 05403-010, Brazil.

出版信息

J Glob Antimicrob Resist. 2019 Mar;16:147-149. doi: 10.1016/j.jgar.2018.12.021. Epub 2019 Jan 8.

Abstract

OBJECTIVES

Pseudomonas aeruginosa is a Gram-negative bacterium that causes severe infections, especially in hospitalised and immunocompromised patients. Polymyxins are the last therapeutic option to treat infections caused by this micro-organism. Here we describe a polymyxin-resistant P. aeruginosa assigned as sequence type (ST) 245 for the first time in Brazil.

METHODS

Antimicrobial susceptibility testing of the isolate was performed. In addition, whole-genome sequencing was performed and its virulence and resistance genes were analysed.

RESULTS

The P. aeruginosa ST245 isolate was identified for the first time in Brazil in a patient with ventilator-associated pneumonia hospitalised at Hospital das Clínicas, São Paulo. Analysis of the genome showed the presence of several resistance and virulence genes. Mutations in β-lactam resistance genes were found in β-lactamases, outer membrane proteins, efflux pump and penicillin-binding proteins. Polymorphisms related to pathways leading to polymyxin resistance are also present, such as lipid A or keto-deoxyoctulosonate modification with aminoarabinose as well as activation of lipopolysaccharide (LPS).

CONCLUSION

Such findings may represent an alert for the spread of an unusual profile in the country.

摘要

目的

铜绿假单胞菌是一种革兰氏阴性细菌,可导致严重感染,尤其是在住院和免疫功能低下的患者中。多粘菌素是治疗该微生物引起的感染的最后一种治疗选择。在这里,我们首次在巴西描述了一种多粘菌素耐药的铜绿假单胞菌,其序列类型(ST)为 245。

方法

对分离株进行了抗菌药物敏感性测试。此外,还进行了全基因组测序,并对其毒力和耐药基因进行了分析。

结果

首次在巴西圣保罗临床医院住院的呼吸机相关性肺炎患者中发现了铜绿假单胞菌 ST245 分离株。对基因组的分析显示存在多种耐药和毒力基因。在β-内酰胺酶、外膜蛋白、外排泵和青霉素结合蛋白中发现了β-内酰胺类耐药基因的突变。与导致多粘菌素耐药的途径相关的多态性也存在,如脂质 A 或酮-脱氧辛糖酸盐与氨基阿拉伯糖的修饰以及脂多糖(LPS)的激活。

结论

这些发现可能表明该国出现了一种不寻常的耐药模式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验